A. Scott Anderson - 17 Jun 2021 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 19:14:49 UTC
Previous filing
20 May 2021
Next filing
09 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +2,914 +6.6% $0.000000 47,085 17 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMSI Non-qualified stock options (right to buy) 5,000 17 Jun 2021 Common Stock 5,000 $18.80 Direct F2
holding MMSI Non-qualified stock options (right to buy) 10,000 17 Jun 2021 Common Stock 10,000 $34.40 Direct F3
holding MMSI Non-qualified stock options (right to buy) 25,000 17 Jun 2021 Common Stock 25,000 $50.50 Direct F4
holding MMSI Non-qualified stock options (right to buy) 13,750 17 Jun 2021 Common Stock 13,750 $52.17 Direct F5
holding MMSI Non-qualified stock options (right to buy) 7,500 17 Jun 2021 Common Stock 7,500 $52.17 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022, 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021, and 39,983 shares of common stock. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date.
F2 Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
F3 Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
F4 Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
F5 Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
F6 Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.